Global Pharmaceutical & Biotechnology Outlook 2014: Mature Biotech

1
Global Pharmaceutical Biotechnology Outlook
2014 Mature Biotech
One-Stop Shop for Business Information
2
Summary
Positive sentiments for the biotech sector have
prevailed in the last two to three years, and we
expect this trend to continue for the next year
too. Our optimism is based on the continuity in
the flow of innovative products from their
pipeline, implementation of strategic decisions
to improve cost efficiency, strengthen
therapeutic leadership, and hedge against generic
threats which all lend stability to the
business model of the company. Focus and interest
in Orphan diseases remains and Alexion kept
everyone guessing on the possible acquisition.
BMRN, Alexion are likely candidates to be
acquired in this space.
3
In the next five years the distinction between
some mature biotech companies and large global
pharma may become blurred esp. if there is
consolidation within the sector. AMGN was the
first amongst the peers to declare a dividend and
this has raised the bar/expectations from others
too. First mAb Biosimilar (Hospiras infliximab
Inflectra) was approved in EU and the pipeline,
competition intensifies despite no firm
regulatory pathway is defined in US. The
detailed 72 pages report contains the detailed
discussion of the key attributes of leading
biotech companies Acorda, Alexion, Amgen, Biogen
Idec, Celgene, Gilead, Regeneron and Vertex. 
4
Table Of Content

1. Macro Analysis
2. In-depth Company Analysis and Reports on
3. Acorda Therapeutics
4. Alexion Pharma
5. Amgen
6. Biogen Idec
7. Celgene
8. Gilead Sciences
9. Regeneron
10. Vertex Pharma
11. Industry Tables

5
Related Reports

• Membrane Technology Market in Pharmaceutical,
  Biopharma and Life Sciences - Global Industry
  Analysis, Size, Share, Growth, Trends and
  Forecast, 2014 - 2019
• Mass Spectrometry Market - by Technology by
  Application - Global Trends Forecast to 2018
• Specialty Enzymes Market by Source, Type,
  Application Geography - Global Trends
  Forecasts to 2018
• Kazakhstan Pharmaceuticals and Healthcare Report
• The Chinese Pharmaceuticals Market to 2024

6
Custom Research

• Incase the reports dont match your
  requirement then we can do a Custom Research for
  you. Our multifarious capabilities, cross-sector
  expertise and detailed knowledge of various
  markets, put us at a unique position to take up
  Custom Research demands of yours. We provide the
  specifications of the custom research job to a
  dedicated team comprising of researchers,
  analysts and industry experts, who have close
  experience and understanding of global markets,
  competitive landscapes, various business models,
  market shares, drivers, restraints and benchmarks.

7

• To know more
• Global Pharmaceutical Biotechnology Outlook
  2014 Mature Biotech

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com